FreeStyle Optium Neo
Guides patients to take a more active role in managing blood glucose trends. Accurate blood glucose testing Small sample, results in seconds, no coding Uses individually foil-wrapped test strips, designed to guarantee a reliable result every time Blood glucose trend indicators Notifies your patients when they may be experiencing hypo- or hyperglycaemic trends2 Prompts your patients to take action as needed Arr…
Receive your quote directly from the manufacturer.
Accurate Results
Check Sugar level of patients
The strips really accurate and handy. The amount of blood required is also comparably less.
Review Date: 30 Jul 2022 | Abbott
Guides patients to take a more active role in managing blood glucose trends.
Accurate blood glucose testing
- Small sample, results in seconds, no coding
- Uses individually foil-wrapped test strips, designed to guarantee a reliable result every time
Blood glucose trend indicators
- Notifies your patients when they may be experiencing hypo- or hyperglycaemic trends2
- Prompts your patients to take action as needed
- Arrows flash if tests are high or low within the same time period over a number of days
Designed to help patients stay on track with their prescribed insulin regimen
Insulin dose guide
- Stores and displays your insulin dosing guidance for basal and mealtime insulins (requires HCP set-up)
- Patients simply tap up or down arrows to accurately log their insulin dose
Insulin logging
- Insulin doses can be recorded in the meter memory for easy review
- Designed to help patients avoid mistakes, such as skipping a dose or taking the same dose twice
- Insulin logging can be used even if the insulin dose guide is not set-up
Revolutionizing CGM with FreeStyle Libre
This video presents a guide to the FreeStyle® Libre from Abbott, which has recently been approved by the U.S. Food and Drug Administration. For the 30.3 million Americans who have diabetes, FDA approval is a potentially life-changing experience. This flash glucose monitoring system aims to replace blood glucose testing and is used for detecting trends and patterns in order to help recognize episodes of hyper- and hypo-glycemia, facilitating insulin therapy adjustments. The revolutionary system contains a factory pre-set calibration and therefore eliminates the hurdles of traditional glucose monitoring and requires no routine fingersticks or fingerstick calibrations.
New data shows that Abbott’s FreeStyle Libre System reduces diabetes-related hospitalizations for people with type 2 diabetes on once-daily insulin therapy
FreeStyle Libre system can help reduce acute diabetes-related events, such as severe hypoglycaemia and diabetic ketoacidosis, leading to a 67% drop in hospitalizations
Abbott, CamDiab and Ypsomed unveil new automated insulin delivery partnership for people with diabetes
The three companies will work to accelerate development of automated insulin delivery system for people living with diabetes
Abbott, Tandem Diabetes Care advance development of technologies for insulin delivery systems
Companies partner to integrate Abbott's FreeStyle Libre continuous glucose monitoring technology with Tandem's insulin delivery products to provide options to simplify and tailor diabetes management
Data shows Abbott's FreeStyle Libre system dramatically decreases diabetic ketoacidosis-related hospitalizations
Additional real-world data demonstrate meaningful outcomes for people living with diabetes who use Abbott's glucose sensing technology
Abbott's CGM technology available for hospitalized diabetic patients with COVID-19
The FreeStyle Libre 14 day system can be used by frontline healthcare workers tackling the coronavirus
